Related references
Note: Only part of the references are listed.Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
Andreas Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244
Peter J. Hoskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
Massimo Federico et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)
Michal Sieniawski et al.
BLOOD (2008)
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Volker Diehl et al.
TRANSFUSION AND APHERESIS SCIENCE (2007)
Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma
Armando Santoro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Early treatment-related mortality in adult autologous stem cell transplant recipients:: a nation-wide survey of 1482 transplanted patients
E Jantunen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)
PWM Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: A comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation
DL Forrest et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
V Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
DB Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
